Cart
sales@molnova.com
androsin
CAS No. 531-28-2
androsin( —— )
Catalog No. M21513 CAS No. 531-28-2
Androsin isolated from Picrorhiza Kurroa Royle ex Benth has anti-asthmatic effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 51 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 44 | In Stock |
|
| 10MG | 62 | In Stock |
|
| 25MG | 102 | In Stock |
|
| 50MG | 149 | In Stock |
|
| 100MG | 220 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Nameandrosin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAndrosin isolated from Picrorhiza Kurroa Royle ex Benth has anti-asthmatic effects.
-
DescriptionAndrosin isolated from Picrorhiza Kurroa Royle ex Benth has anti-asthmatic effects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number531-28-2
-
Formula Weight328.31
-
Molecular FormulaC15H20O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (380.74 mM)
-
SMILESCC(c(cc1)cc(OC)c1O[C@@H]([C@@H]([C@H]1O)O)O[C@H](CO)[C@H]1O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dorsch W et al. Antiasthmatic effects of Picrorhiza kurroa: androsin prevents allergen- and PAF-induced bronchial obstruction in guinea pigs. Int Arch Allergy Appl Immunol. 1991;95(2-3):128-33.
molnova catalog
related products
-
4-Hydroxy-L-phenylgl...
4-Hydroxy-L-(+)-2-phenylglycine is a carnitine palmitoyltransferase-1 inhibitor. 4-Hydroxy-L-(+)-2-phenylglycine improves whole-body glucose tolerance and insulin sensitivity in high-fat diet-induced obese mouse with insulin resistance.
-
HA15
HA15 targets specifically BiP/GRP78/HSPA5. HA15 exhibits anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.
-
Vixarelimab
Vixarelimab (KPL-716) is a human anti-oncostatin M (OSM) monoclonal antibody with affinity for the beta chain of the OSM receptor, inhibiting IL-31 and OSM signaling.
